FDA Clearance Tracker · P860026-S008
DIAPHRAGMATIC PACEMAKER PHRENIC NERVE STIMULATOR
Last checked: Nov 21, 2026Latest source record: Mar 3, 2003 (this decision)Source: openFDAMethods & limitations
Decided
Mar 3, 2003
Approved
Time to decision
173 days
Received Sep 11, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P860026-S008
- Device name
- DIAPHRAGMATIC PACEMAKER PHRENIC NERVE STIMULATOR
- Applicant
- Avery Biomedical Devices, Inc.
- Applicant location
- Commack, NY
- Received
- Sep 11, 2002
- Decided
- Mar 3, 2003
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P860026
Device type
- Device class
- Class III
- Regulation
- 21 CFR 882.5830
FDA's approval statement
As written in FDA's record.
APPROVAL FOR SELECTING A FINAL VALUE OF C22 AND C50 CAPACITORS DURING PRODUCTION TESTING BASED ON PARAMETERS MEASURED WITH CALIBRATED TEST EQUIPMENT TO RESULT IN PEAK OPERATING PERFORMANCE OF THE TRANSMITTER.
Source documents
Other decisions for Avery Biomedical Devices, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.